retatrutide alternative vs Eloralintide Obesity Therapies from Eli Lilly | Ahmad Bahareth, MD posted on the topic Retatrutide vs Mounjaro: 24% vs

Kwatra S et al

Comparative Incretin Research: Retatrutide has been studied in direct comparison with dual agonists like Tirzepatide and single agonists like Semaglutide in pre-clinical models, with research examining how the addition of GCGR agonism modifies metabolic outcomes providing direct pharmacological insight into the incremental value of each receptor target within the tri-agonist framework

They are recognized as effective therapies for glycemic control, with additional benefits in weight reduction and cardiovascular risk

Urva S, Coskun T, Loh MT, et al

Wegovy is FDA-approved specifically for chronic weight management at a higher dose of 2.4 mg per week

The goal is to find the dose that delivers meaningful weight loss benefits while keeping side effects manageable and costs more affordable